FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Lorazepam by Hikma Pharmaceuticals USA Inc., authorizing modifications under the supplement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder
• Insomnia
• Seizure Disorders
• Status Epilepticus

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

SUPPL AP for LORAZEPAM (LORAZEPAM)